Moran A.M. Dunitz J. Nathan B. Saeed A. Holme B. Thomas W.

Cystic fibrosis-related diabetes: current trends in prevalence, incidence, and mortality.

Diabetes Care. 32: 1626-1631Guo J.H. Chen H. Ruan Y.C. Zhang X.L. Zhang X.H. Fok K.L. et al.

Glucose-induced electrical activities and insulin secretion in pancreatic islet β-cells are modulated by CFTR.

Nat Commun. 5: 4420Meacham L.R. Caplan D.B. McKean L.P. Buchanan C.N. Parks J.S. Culler F.L.

Preservation of somatostatin secretion in cystic fibrosis patients with diabetes.

Arch Dis Child. 68: 123-125

Update on cystic fibrosis-related diabetes.

J Cyst Fibros. 12: 318-331Moheet A. Mangia S. Seaquist E.R.

Impact of diabetes on cognitive function and brain structure.

Annu New York Acad Sci. 1353: 60-71

The final frontier: how does diabetes affect the brain?.

Diabetes. 59: 4-5Lyoo I.K. Yoon S. Renshaw P.F. Hwang J. Bae S. Musen G. et al.

Network-level structural abnormalities of cerebral cortex in type 1 diabetes mellitus.

PLoS One. 8Biessels G.J. Staekenborg S. Brunner E.J. Brayne C. Scheltens P.

Risk of dementia in diabetes mellitus: a systematic review.

Lancet Neurol. 5: 64-74Rucker J.L. Mcdowd J.M. Kluding P.M.

Executive function and type 2 diabetes : putting the pieces together.

Phys Ther. 92: 454-462Biessels G.J. Deary I.J. Ryan C.M.

Cognition and diabetes: a lifespan perspective.

Lancet Neurol. 7: 184-190McCrimmon R.J. Ryan C.M. Frier B.M.

Diabetes and cognitive dysfunction.

Lancet. 379: 2291-2299Zilliox L.A. Chadrasekaran K. Kwan J.Y. Russell J.W.

Diabetes and Cognitive Impairment.

Curr Diab Rep. 16: 87Lamport D.J. Lawton C.L. Mansfield M.W. Dye L.

Impairments in glucose tolerance can have a negative impact on cognitive function: a systematic research review.

Neurosci Biobehav Rev. 33: 394-413Dobbin C.J. Bartlett D. Melehan K. Grunstein R.R. Bye P.T.P.

The Effect of Infective Exacerbations on Sleep and Neurobehavioral Function in Cystic Fibrosis.

Am J Respir Crit Care Med. 172: 99-104Crews W.D. Jefferson A.L. Broshek D.K. Barth J.T. Robbins M.K.

Neuropsychological Sequelae in a Series of Patients with End-Stage Cystic Fibrosis: Lung Transplant Evaluation.

Arch Clin Neuropsychol. 15: 59-70Dancey D.R. Tullis E. Heslegrave R. Thornley K. Hanly P.J.

Sleep quality and daytime function in adults with cystic fibrosis and severe lung disease.

Eur Respir J. 19: 504-510Borschuk A. Molitor S. Everhart R. Siracusa C. Filigno S.

Executive functioning in pediatric cystic fibrosis: a preliminary study and conceptual model.

Pediatr Pulmonol. 55: 939-947Piasecki B. Turska-Malinska R. Matthews-Brzozowska T. Mojs E.

Executive function in pediatric patients with cystic fibrosis, inflammatory bowel disease and in healthy controls.

Eur Rev Med Pharmacol Sci. 20: 4299-4304Koscik R.L. Farrell P.M. Kosorok M.R. Zaremba K.M. Laxova A. Lai H.-C. et al.

Cognitive Function of Children With Cystic Fibrosis: Deleterious Effect of Early Malnutrition.

Paediatrics. 113: 1549-1558Kent A. Murphy G.H. Milla P.

Psychological characteristics of children with Shwachman syndrome.

Arch Dis Childhood. 65: 1349-1352https://doi.org/10.1136/adc.65.12.1349

Stewart S.M., Campbell R.A., Kennard B., Nici J., Silver C.H., Waller D.A., Uauy R. Neuropsychological Correlates of Cystic Fibrosis in Patients 5 to 8 Years Old. Children's Health Care. 1995; 24(3): 159–173. 10.1017/CBO9781107415324.004

Stewart S.M. Campbell R.A. McCallon D. Waller D.A. Andrews W.S.

Cognitive patterns in school-age children with end-stage liver disease.

J Dev Behav Pediatr. 13: 331-338Maddrey A.M Cullum C.M. Prestidge C.

464. Cognitive Dysfunction in Adults with CF.

Pediatr Pulmonol. 23: 322https://doi.org/10.1002/ppul.1950230706Maddrey A.M. Cullum C.M. Prestidge C.

Neuropsychological Dysfunction in Adults with Cystic Fibrosis.

Arch Clin Neuropsychol. 13: 118-119https://doi.org/10.1017/CBO9781107415324.004Elce V. Del Pizzo A. Nigro E. Frisso G. Martiniello L. et al.

Impact of physical activity on cognitive functions: a new field for research and management of cystic fibrosis.

Diagnostics. 10: 489Reznikov L.R. Dong Q. Chen J.H. Moninger T.O. Park J.M. et al.

CFTR-deficient pigs display peripheral nervous system defects at birth.

Proc Natl Acad Sci. 110: 3083-3088El-Salem K. Aburahma S. Rawashdeh M.

Peripheral nerve dysfunction in patients with cystic fibrosis.

J Clin Neurophysiol. 27: 216-218Robbins T.W. James M. Owen A.M. Sahakian B.J. McInnes L. Rabbitt P.

Cambridge Neuropsychological Test Automated Battery (CANTAB): a Factor Analytic Study of a Large Sample of Normal Elderly Volunteers.

Dement Geriatr Cogn Disord. 5: 266-281Peckham D.G. Etherington C. White H. Mehta A. Shaw N. Morton A.M. et al.

The development and deployment of integrated electronic care records in a regional adult and paediatric cystic fibrosis unit.

J Cyst Fibros. 13: 681-686

EuroQol–a new facility for the measurement of health-related quality of life..

Health Policy. 16 (): 199-208Parrott A.C. Hindmarch I.

Factor analysis of a sleep evaluation questionnaire.

Psychol Med. 8: 325-329

Performance tests in human psychopharmacology (2): content validity, criterion validity, and face validity.

Hum Psychopharmacol. 6: 91-98Corcoran T.E. Godovchik J.E. Donn K.H. Busick D.R. Goralski J. Locke L.W. et al.

Overnight delivery of hypertonic saline by nasal cannula aerosol for cystic fibrosis.

Pediatr Pulmonol. 52: 1142-1149

The hospital anxiety and depression scale.

Acta Psychiatr Scand. 67: 361-370White D. Leach C. Sims R. Cottrell D.

Validation of the Hospital Anxiety and Depression Scale for use with adolescents.

Br J Psychiatry. 175: 452-454Bjelland I. Dahl A.A. Tangen T. Neckelmann D.

The validity of the Hospital Anxiety and Depression Scale An updated literature review.

J Psychosom Res. 52: 69-77Gonçalves M.M. Pinho M.S. Simões M.R.

Test–retest reliability analysis of the Cambridge Neuropsychological Automated Tests for the assessment of dementia in older people living in retirement homes.

Appl Neuropsychol Adult. 23: 251-263

Patterns of cognitive ageing.

Psychol Res. 63: 308-316

Test/re-test reliability of the CANTAB and ISPOCD neuropsychological batteries: theoretical and practical issues.

Neuropsychologia. 36: 915-923Lasselin J. Layé S. Barreau J.-B. Rivet A. Dulucq M.-J. Gin H. et al.

Fatigue and cognitive symptoms in patients with diabetes: Relationship with disease phenotype and insulin treatment.

Psychoneuroendocrinology. 37: 1468-1478De Luca C.R. Wood S.J. Anderson V. Buchanan J. Proffitt T.M. Mahony K. et al.

Normative Data From the Cantab I: development of Executive Function Over the Lifespan.

J Clin Exp Neuropsychol. 25: 242-254

Luciana M., Nelson C.A. Neurodevelopmental assessment of cognitive function using the Cambridge Neuropsychological Testing Automated Battery (CANTAB): validation and future goals. In: Ernst M, Rumsey JM, editors. Functional Neuroimaging in Child Psychiatry. 2000. p. 379–97.

Age-related impairment in long-term potentiation in hippocampus: a role for the cytokine, interleukin-1β?.

Prog Neurobiol. 56: 571-589Ba-Tin L. Strike P. Tabet N.

Diabetic Peripheral Microvascular Complications: Relationship to Cognitive Function.

Cardiovasc Psychiatry Neurol. 2011: 1-7Wrighten S.A. Piroli G.G. Grillo C.A. Reagan L.P.

A look inside the diabetic brain: Contributors to diabetes-induced brain aging.

Biochim Biophys Acta - Mol Basis Dis. 1792: 444-453Hwang M. Tudorascu D.L. Nunley K. Karim H. Aizenstein H.J. Orchard T.J. et al.

Brain Activation and Psychomotor Speed in Middle-Aged Patients with Type 1 Diabetes: Relationships with Hyperglycemia and Brain Small Vessel Disease.

J Diabetes Res. 20169571464McNay E.C. Fries T.M. Gold P.E.

Decreases in rat extracellular hippocampal glucose concentration associated with cognitive demand during a spatial task.

Proc Natl Acad Sci USA. 97: 2881-2885

Demystifying cognitive flexibility: Implications for clinical and developmental neuroscience.

Trends Neurosci. 38: 571-578

Executive Function.

Annu Rev Psychol. 64: 135-168Frost F. Walshaw M.J. Nazareth D.

Cystic fibrosis-related diabetes: an update.

QJM. : 1-4https://doi.org/10.1093/qjmed/hcaa256van Duinkerken E. Ryan C.M.

Diabetes mellitus in the young and the old: Effects on cognitive functioning across the life span.

Neurobiol. Dis. 134104608Bellin M.D. Laguna T.A. Leschyshyn J. Regelmann W.E. Dunitz J. Billings J. et al.

Insulin secretion improves in cystic fibrosis following ivacaftor correction of CFTR: a small pilot study.

Pediatr Diabetes. 14: 417-421

Role of inflammation in cognitive impairment: results of observational epidemiological studies and clinical trials.

Annu New York Acad Sci. 1207: 155-162Marsland A. Gianaros P.J. Kuan D.C. Sheu L.K. Krajina K. Manuck S.B.

Brain morphology links systemic inflammation to cognitive function in midlife adults.

Brain Behav Immun. 48: 195-204Marsland A.L. Petersen K.L. Sathanoori R. Muldoon M.F. Neumann S.A. Ryan C. et al.

Interleukin-6 covaries inversely with cognitive performance among middle-aged community volunteers.

Psychosom Med. 68: 895-903

Expression of interleukin-6 (IL-6) and interleukin receptor (IL-6R) mRNAs in rat brain during postnatal development.

Brain Res. 637: 10-14Vitkovic L. Konsman J.P. Bockaert J. Dantzer R. Homburger V. Jacque C.

Cytokine signals propagate through the brain.

Mol Psychiatry. 5: 604-615Bettcher B.M. Wilheim R. Rigby T. Green R. Miller J.W. Racine C.A. et al.

C-reactive protein is related to memory and medial temporal brain volume in older adults.

Brain Behav Immun. 26: 103-108Gianaros P.J. Marsland A.L. Sheu L.K. Erickson K.I. Verstynen T.D.

Inflammatory pathways link socioeconomic inequalities to white matter architecture.

Cereb Cortex. 23: 2058-2071Beydoun M.A. Dore G.A. Canas J.A. Liang H. Beydoun H.A. Evans M.K. et al.

Systemic inflammation is associated with longitudinal changes in cognitive performace among urban adults.

Front Aging Neurosci. 10: 313Schram M.T. Euser S.M. De Craen A.J.M. Witteman J.C. Frolich M. Hofman A. et al.

Systemic markers of inflammation and cognitive decline in old age.

Am Geriatr Soc. 55: 708-716Crisan A.F. Oancea C. Timar B. Fira-Mladinescu O. Tudorache V.

Cognitive impairment in chronic obstructive pulmonary disorder.

PLoS One. 9e102468Cantin A.M. Hartl D. Konstan M.W. Chmiel J.F.

Inflammation in cystic fibrosis lung disease: pathogenesis and therapy.

J Cyst Fibros. 14: 419-430

Mechanisms and markers of airway inflammation in cystic fibrosis.

Eur Respir J. 19: 333-340https://doi.org/10.1183/09031936.02.00229202De Rose V. Burgel P.-R. Gaggar A. Greene C.

Airway Inflammatory/Immune Responses in COPD and Cystic Fibrosis.

Mediators Inflamm. ()Cohen-Cymberknoh M. Kerem E. Ferkol T. Elizur A.

Airway inflammation in cystic fibrosis: molecular mechanisms and clinical implications.

Thorax. 68: 1157-1162https://doi.org/10.1136/thoraxjnl-2013-203204

Drug induced complications; can we do more?.

J Cyst Fibros. 12: 547-558https://doi.org/10.1016/j.jcf.2013.04.014Savage E. Beirne P.V. Ni Chroinin M. Du! A. Fitzgerald T. Farrell D.

Self-management education for cystic fibrosis.

Cochrane Database Syst Rev. 9CD007641https://doi.org/10.1002/14651858.CD007641.pub3Baird C. Lovell J. Johnson M. Shiell K. Ibrahim J.E.

The impact of cognitive impairment on self-management in chronic obstructive pulmonary disease: A systematic review.

Respir. Med. 129: 130-139Wong R.H.X. Scholey A.B. Howe P.R.C.

Assessing Premorbid Cognitive Ability in Adults With Type 2 Diabetes Mellitus—a Review With Implications for Future Intervention Studies.

Current Diabetes Reports. 14: 1-12https://doi.org/10.1007/s11892-014-0547-4Denford S. Mackintosh K.A. McNarry M.A. et al.

Enhancing intrinsic motivation for physical activity among adolescents with cystic fibrosis: a qualitative study of the views of healthcare professionals.

BMJ Open. 9e028996https://doi.org/10.1136/bmjopen-2019-028996

Strategies to optimize treatment adherence in adolescent patients with cystic fibrosis.

Adolesc Health Med Ther. 7: 117-124Grossoehme D.H. Filigno S.S. Bishop M.

Parent routines for managing cystic fibrosis in children.

J Clin Psychol Med Settings. 21: 125-135https://doi.org/10.1007/s10880-014-9396-1George M. Rand-Giovannetti S. Eakin M.N. Borrelli B. Zettler M. Riekert K.A.

Perceptions of barriers and facilitators: Self-management decisions by older adolescents and adults with CF.

J Cyst Fibros. 9: 425-432https://doi.org/10.1016/j.jcf.2010.08.016Bridges N. Rowe R. Holt R.I.G.

Unique challenges of cystic fibrosis-related diabetes.

Diabet Med. 35: 1181-1188https://doi.org/10.1111/dme.13652Quittner A.L. Goldbeck L. Abbott J. et al.

Prevalence of depression and anxiety in patients with cystic fibrosis and parent caregivers: results of The International Depression Epidemiological Study across nine countries.

Thorax. 69: 1090-1097Schechter M.S. Ostrenga J.S. Fink A.K. Barker D.H. Sawicki G.S. Quittner A.L.

Decreased survival in cystic fibrosis patients with a positive screen for depression.

J Cyst Fibros. Cronly J.A. Duff A.J. Riekert K.A. Fitzgerald A.P. Perry I.J. et al.

Health-Related Quality of Life in Adolescents and Adults With Cystic Fibrosis: Physical and Mental Health Predictors.

Respir Care. 64https://doi.org/10.4187/respcare.06356Olveira C. Sole A. Girón R.M. Quintana-Gallego E. Mondejar P. et al.

Depression and anxiety symptoms in Spanish adult patients with cystic fibrosis: associations with health-related quality of life.

General Hospital Psychiatry. 40: 39-46https://doi.org/10.1016/j.genhosppsych.2016.02.002Abbott J. Morton A.M. Hurley M.A. et al.

Longitudinal impact of demographic and clinical variables on health-related quality of life in cystic fibrosis.

BMJ Open. 5e007418https://doi.org/10.1136/bmjopen-2014-007418

Role of Inflammation in Depression and Treatment Implications.

Handb Exp Pharmacol. 250 (): 255-286https://doi.org/10.1007/164_2018_166Macdonald M. Lang A. Savage E. Chappe V. Murphy A. et al.

Working to Have a Normal Life With Cystic Fibrosis in an Adherence-Driven Health Care System.

Respir Care. 64: 945-952Abbott J. Holt A. Morton A.M. Hart A. Milne G. Wolfe S. et al.

Patient indicators of a pulmonary exacerbation: reports from children map onto those of adults.

J Cyst Fibros. 11: 180-186McCourt F. O’Neill B. Logan I. Abbott J. Plant B. McCrum-Gardner E. et al.

Indicators of pulmonary exacerbation in cystic fibrosis: a delphi survey of patients and health professionals.

J Cyst Fibros. 14: 90-96Toplak M.E. West R.F. Stanovich K.E.

Practitioner Review: do performance-based measures and ratings of executive function assess the same constuct?.

J Child Psychol Psychiatry. 54: 131-143